Accessibility Menu
 
Scorpius logo

Scorpius

(NYSEMKT) HTBX

Current PriceN/A
Market CapN/A
Since IPO (2013)-100%
5 Year-100%
1 Year-89%
1 Month+24%

Scorpius Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$6.91T

Net Income (TTM)

$48.59T

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

HTBX: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Scorpius

Industry

Biotechnology

Employees

90

CEO

Jeff A. Wolf, MBA

Headquarters

Morrisville, NC 27560, US

HTBX Financials

Key Financial Metrics (TTM)

Gross Margin

43%

Operating Margin

-6%

Net Income Margin

-7%

Return on Equity

-174%

Return on Capital

30%

Return on Assets

-2%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Short Interest

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$2.11M

Operating Income

$35.42M

EBITDA

$35.55M

Operating Cash Flow

$0.00

Capital Expenditure

$0.00

Free Cash Flow

$0.00

Cash & ST Invst.

$8.05M

Total Debt

$1.67M

Scorpius Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2025YOY CHG

Revenue

$229.84B

+108202594.7%

Gross Profit

$84.47B

+39766774.7%

Gross Margin

36.75%

N/A

Market Cap

N/A

N/A

Market Cap/Employee

N/A

N/A

Employees

49

N/A

Net Income

$984.43B

-11845505.0%

EBITDA

$4.73T

-60130248.7%

Quarterly Fundamentals

Name
Q3 2025YOY CHG

Net Cash

$17.52T

-21348207.7%

Accounts Receivable

$179.89B

+180419136.7%

Inventory

$203.48B

N/A

Long Term Debt

$5.51T

+393332214.5%

Short Term Debt

$12.61T

+1897153323.8%

Return on Assets

-2.34%

N/A

Return on Invested Capital

29.70%

N/A

Free Cash Flow

$2.92T

-25804629.4%

Operating Cash Flow

$2.92T

-28560123.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ACHLAchilles Therapeutics plc
$1.48+0.68%
RPHMReneo Pharmaceuticals, Inc.
$18.20+952.02%
TCRRTCR2 Therapeutics Inc.
$1.48+0.00%
SGTXSigilon Therapeutics, Inc.
$22.47-2.56%

Trending Stocks

Symbol / CompanyPricePrice Chg
CYCNCyclerion Therapeutics
$6.33+3.09%
NVDANvidia
$177.00+0.01%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.74+0.05%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.82+0.06%

Questions About HTBX

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.